Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings
- 1 November 2018
- journal article
- research article
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 61, 111-128
Abstract
No abstract availableKeywords
This publication has 298 references indexed in Scilit:
- Antimicrobial peptides and gut microbiota in homeostasis and pathologyEMBO Molecular Medicine, 2013
- Role of Endogenous Microbiota, Probiotics and Their Biological Products in Human HealthNutrients, 2013
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4Cancer Cell, 2012
- Role of the Commensal Microbiota in Normal and Pathogenic Host Immune ResponsesCell Host & Microbe, 2011
- Intestinal microbiota in human health and disease: the impact of probioticsGenes & Nutrition, 2011
- Current Concepts of the Intestinal Microbiota and the Pathogenesis of InfectionCurrent Infectious Disease Reports, 2010
- Enterobacteriaceae Act in Concert with the Gut Microbiota to Induce Spontaneous and Maternally Transmitted ColitisCell Host & Microbe, 2010
- Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in IntestineCell, 2010
- Gut Commensal Bacteria Direct a Protective Immune Response against Toxoplasma gondiiCell Host & Microbe, 2009
- C-type lectins and phagocytosisImmunobiology, 2009